A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma

Clinical trial NCT03418922 · COMPLETED

Trial details

NCT number: NCT03418922
Sponsor: Eisai Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2018-01-16
Primary completion: 2022-12-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.